Approval · Notice of Compliance 4611 · 1996
PANCURONIUM: Notice of Compliance 4611
Issued August 6, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4611
- Date
- August 6, 1996
- Company
- Bdh Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Nondepolarizing neuromuscular blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PANCURONIUM | 02227487 | — |
| PANCURONIUM | 02227495 | — |
Medicinal ingredients
- PANCURONIUM BROMIDE 1 MG per ML
- PANCURONIUM BROMIDE 2 MG per ML